Pharmaceutical costs for inflammatory bowel disease units - An issue for department heads? The GESTIONAEII survey

Rev Esp Enferm Dig. 2016 Jun;108(6):380-1. doi: 10.17235/reed.2016.4192/2016.

Abstract

Inflammatory bowel disease (IBD) units have a relevant weight within gastroenterology departments. In order to gain insight into the managerial aspects of IBD diagnosis and treatment, SEPD submitted a survey (GESTIONAEII) to department heads, IBD specialists, and other gastroenterologists. In this letter, we discuss the results obtained from gastroenterology department heads.

MeSH terms

  • Drug Costs
  • Health Care Surveys
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / economics*
  • Spain